Clinical Trials

Randomized Controlled Trials Phase 3 Trials Drug Efficacy Efficacy Studies Patient Outcomes Vitamin D Studies Phase III Trials Dietary Interventions Phase II Trials Data Analysis

3 ARTICLES

2w ago

Stem-Cell Dopamine Grafts Found Feasible and Safe at One Year in Parkinson’s Trial

The phase 1/2 STEM-PD report shows no serious cell-related harms and early signs of graft survival while investigators plan longer follow-up and larger studies.

3 ARTICLES

4w ago

Chip-Based Metasurface Detects Traumatic Brain Injury Biomarkers at Femtogram Levels

11 ARTICLES

last mo.

GLP‑1 Drugs Move into the Mainstream as UK Clears Oral Wegovy and Tirzepatide Shows Bigger Weight Loss

5 ARTICLES

last mo.

Dapagliflozin Cuts Heart-Failure Hospitalizations by About 80% in People With Cardiomyopathy Genes

3 ARTICLES

last mo.

Mouse Study Finds Semaglutide Directly Reprograms Liver Cells to Ease Disease Without Weight Loss

3 ARTICLES

3mo ago

Screening-Detected AF Carries Early, Threefold Heart Failure Risk in Swedish Trials

3 ARTICLES

3mo ago

Boehringer Ingelheim Transfers CT-155 Commercial Rights to Click Therapeutics With $50 Million Backing

4 ARTICLES

4mo ago

GLP-1 Drugs Linked to Lower Addiction Risk and Harm in Large VA Study

10 ARTICLES

4mo ago

FDA Grants Accelerated Approval to Kresladi, First Gene Therapy for Severe Pediatric LAD-1

6 ARTICLES

4mo ago

GLP-1 Drugs Tied to Lower Addiction Risk and Fewer Severe Outcomes in Major BMJ Analysis

3 ARTICLES

4mo ago

Pilot Trial Signals Low-Dose Lithium May Slow Verbal Memory Decline in Mild Cognitive Impairment

5 ARTICLES

5mo ago

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

3 ARTICLES

5mo ago

Scientific Review Flags He Shou Wu as Multi-Pathway Candidate for Androgenetic Alopecia

Clinical Trials

Stem-Cell Dopamine Grafts Found Feasible and Safe at One Year in Parkinson’s Trial

Chip-Based Metasurface Detects Traumatic Brain Injury Biomarkers at Femtogram Levels

GLP‑1 Drugs Move into the Mainstream as UK Clears Oral Wegovy and Tirzepatide Shows Bigger Weight Loss

Dapagliflozin Cuts Heart-Failure Hospitalizations by About 80% in People With Cardiomyopathy Genes

Low-Dose Quetiapine Improves Sleep but Impairs Next-Day Alertness and Driving

BMJ Review Finds Calcium and Vitamin D Do Not Prevent Fractures or Falls

Mexico Seeks Role as Latin America Clinical-Trial Hub With New Funding and AI

Experimental KRAS Drug Nearly Doubles Survival in Advanced Pancreatic Cancer

Trial Hints ‘Gut Reset’ May Slow Weight Regain After Stopping GLP‑1 Drugs

VDR Gene Variant Tied to 19% Lower Diabetes Risk With High-Dose Vitamin D3

Never miss stories about

Clinical Trials

Medicus Pharma Reports Long-Acting Hormone Control in Phase 1 Teverelix Data

Mouse Study Finds Semaglutide Directly Reprograms Liver Cells to Ease Disease Without Weight Loss

Screening-Detected AF Carries Early, Threefold Heart Failure Risk in Swedish Trials

Boehringer Ingelheim Transfers CT-155 Commercial Rights to Click Therapeutics With $50 Million Backing

GLP-1 Drugs Linked to Lower Addiction Risk and Harm in Large VA Study

FDA Grants Accelerated Approval to Kresladi, First Gene Therapy for Severe Pediatric LAD-1

GLP-1 Drugs Tied to Lower Addiction Risk and Fewer Severe Outcomes in Major BMJ Analysis

Pilot Trial Signals Low-Dose Lithium May Slow Verbal Memory Decline in Mild Cognitive Impairment

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

Scientific Review Flags He Shou Wu as Multi-Pathway Candidate for Androgenetic Alopecia

Never miss stories about

Clinical Trials